MRD-Guided Consolidation Therapy Following Definitive Radiotherapy in Esophageal Cancer
Clinical trial NCT06498752 · RECRUITING
Trial details
- NCT number
- NCT06498752
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-16
- Primary completion
- 2025-06-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.